Brand Name
Aimovig
Generic Name
Erenumab-Aooe
View Brand Information FDA approval date: May 22, 2018
Form: Injection
What is Aimovig (Erenumab-Aooe)?
AIMOVIG is indicated for the preventive treatment of migraine in adults. AIMOVIG is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
GENESIS: AIMOVIG® Pregnancy Exposure Registry
Summary: The primary objective of this study is to estimate the proportion of major congenital malformations in infants of women with migraine exposed to erenumab-aooe during pregnancy compared to infants of women with migraine unexposed to erenumeb-aooe.
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Summary: This is a placebo-controlled, multi-arm phase II platform screening trial designed to test the safety, pain responses, and pharmacodynamic activity of multiple experimental therapies simultaneously in participants with moderate-to-severe pain due to schwannomatosis (SWN). This Master Study is being conducted as a platform that may allow participants with pain associated with schwannomatosis to rec...
Treatment of Acute Post-Traumatic Headache With Erenumab 140 mg, Military Service Members and Civilians With Mild TBI: A Randomized, Double Blind, Placebo Controlled, Multicenter 12-week Duration Study Followed by a 4-week Open-Label Safety Extension
Summary: This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).
Related Latest Advances
Brand Information
AIMOVIG (erenumab-aooe)
1INDICATIONS AND USAGE
AIMOVIG is indicated for the preventive treatment of migraine in adults.
2DOSAGE FORMS AND STRENGTHS
AIMOVIG is a sterile, clear to opalescent, colorless to light yellow solution available as follows:
- Injection: 70 mg/mL in a single-dose prefilled SureClick
- Injection: 140 mg/mL in a single-dose prefilled SureClick
- Injection: 70 mg/mL in a single-dose prefilled syringe
- Injection: 140 mg/mL in a single-dose prefilled syringe
3CONTRAINDICATIONS
AIMOVIG is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients. Reactions have included anaphylaxis and angioedema
4ADVERSE REACTIONS
The following serious adverse reactions are described below and elsewhere in the labeling:
- Hypersensitivity Reactions
- Constipation with Serious Complications
- Hypertension
- Raynaud's Phenomenon
4.1Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
The safety of AIMOVIG has been evaluated in 2537 patients with migraine who received at least one dose of AIMOVIG, representing 3040.2 patient-years of exposure. Of these, 2271 patients were exposed to 70 mg or 140 mg once monthly for at least 6 months, 1305 patients were exposed for at least 12 months, and 216 patients were exposed through 5 years.
In placebo-controlled clinical studies (Studies 1, 2, and 3) of 2184 patients, 787 patients received at least one dose of AIMOVIG 70 mg once monthly, 507 patients received at least one dose of AIMOVIG 140 mg once monthly, and 890 patients received placebo during 3 months or 6 months of double-blind treatment
The most common adverse reactions (incidence ≥ 3% and more often than placebo) in the migraine studies were injection site reactions and constipation. Table 1 summarizes the adverse reactions that occurred during the first 3 months in the migraine studies (Studies 1, 2, and 3).
In Studies 1, 2, and 3, 1.3% of patients treated with AIMOVIG 70 mg or 140 mg discontinued double-blind treatment because of adverse events. The most frequent injection site reactions were injection site pain, injection site erythema, and injection site pruritus.
4.2Postmarketing Experience
The following adverse reactions have been identified during postapproval use of AIMOVIG. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Immune System Disorders: Hypersensitivity reactions, including rash, angioedema, and anaphylaxis [see
Gastrointestinal Disorders: Constipation with serious complications [see , oral mucosal ulceration.
Skin and Subcutaneous Tissue Disorders: Rash, alopecia.
Vascular Disorders: Hypertension [see , Raynaud's Phenomenon [see
5DESCRIPTION
Erenumab-aooe is a human immunoglobulin G2 (IgG2) monoclonal antibody that has high affinity binding to the calcitonin gene-related peptide receptor. Erenumab-aooe is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. It is composed of 2 heavy chains, each containing 456 amino acids, and 2 light chains of the lambda subclass, each containing 216 amino acids, with an approximate molecular weight of 150 kDa.
AIMOVIG (erenumab-aooe) injection is supplied as a sterile, preservative-free, clear to opalescent, colorless to light yellow solution for subcutaneous administration. Each 1 mL 70 mg single-dose prefilled autoinjector and 70 mg single-dose prefilled glass syringe contains 70 mg erenumab-aooe, acetate (1.5 mg), polysorbate 80 (0.10 mg), and sucrose (73 mg). Each 1 mL 140 mg single-dose prefilled autoinjector and 140 mg single-dose prefilled glass syringe contains 140 mg erenumab-aooe, acetate (2.0 mg), polysorbate 80 (0.10 mg), and sucrose (65 mg). Enclosed within the autoinjector is a single-dose, prefilled glass syringe. The solution of AIMOVIG has a pH of 5.2.
6CLINICAL STUDIES
The efficacy of AIMOVIG was evaluated as a preventive treatment of episodic or chronic migraine in three randomized, double-blind, placebo-controlled studies: two studies in patients with episodic migraine (4 to 14 migraine days per month) (Study 1 and Study 2) and one study in patients with chronic migraine (≥ 15 headache days per month with ≥ 8 migraine days per month) (Study 3). The studies enrolled patients with a history of migraine, with or without aura, according to the International Classification of Headache Disorders (ICHD-III) diagnostic criteria.
7PATIENT COUNSELING INFORMATION
Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).
8INSTRUCTIONS FOR USE AIMOVIG®[AIM-oh-vig] (erenumab-aooe) injection, for subcutaneous use mg/mL single-dose prefilled SureClick®autoinjector
This Instructions for Use contains information on how to inject AIMOVIG with a SureClick autoinjector.
If your healthcare provider decides that you or a caregiver may be able to give your injections of AIMOVIG at home, you should receive training on the right way to prepare and inject AIMOVIG. Do not try to inject yourself until you have been shown the right way to give the injections by your healthcare provider or nurse.
The medicine in the AIMOVIG autoinjector is for injection under the skin (subcutaneous injection). See the AIMOVIG
Storing and Preparing to Inject AIMOVIG
1 Refrigerate the autoinjector carton until you are ready to use it.
- Keep the autoinjector in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Keep the autoinjector in the original carton to protect it from light or physical damage.
- Do not freeze the autoinjector.
- Do not store the autoinjector in extreme heat or cold. For example, avoid storing in your vehicle's glove box or trunk.
3 You may keep AIMOVIG at room temperature for up to 7 days, if needed.
- For example, when you are traveling, you may keep AIMOVIG at room temperature.
4 Inspect the medicine. It should be clear and colorless to slightly yellow.
- It is okay to see air bubbles.
- Do not use the autoinjector if the medicine is cloudy, discolored, or contains flakes or particles.
5 Check the expiration date (Exp.) and inspect the autoinjector for damage.
- Do not use the autoinjector if the expiration date has passed.
- Do not use the autoinjector if:
- the white cap is missing or loose in carton.
- it has cracks or broken parts, or
- it has been dropped on a hard surface.
Getting Ready to Inject AIMOVIG
6 Gather and place the following items for your injection on a clean, flat, and well-lit surface:
- AIMOVIG autoinjector (room temperature),
- Sharps disposal container [see
- Alcohol wipe,
- Adhesive bandage, and
- Cotton balls or gauze pads.
7 Select 1 of these injection sites.
- Select the thigh or stomach (except for 2 inches around the belly button).
- Someone else can inject in your thigh, stomach, or back of the upper arm.
8 Wash your hands thoroughly with soap and water.
9 Clean the injection site with an alcohol wipe.
- Let the skin dry on its own.
- Do not touch this area again before injecting.
Injecting AIMOVIG
10 Grasp the autoinjector so you can see the window. Pull the white cap straight off. You may need to pull hard.
- Do not twist, bend, or wiggle the white cap to pull it off.
- Never put the white cap back on. It may damage the needle.
- Do not put your finger inside the dark green safety guard.
- It is normal to see a drop of medicine come out of the needle or dark green safety guard.
11 Stretch or pinch the skin to create a firm surface at the injection site until the injection is finished. Place the dark green safety guard straight against the skin.
- Make sure you can see the window.
- Make sure the autoinjector is positioned straight on the injection site (at a 90-degree angle).
12 Firmly push the autoinjector down until the dark green safety guard stops moving. Hold the autoinjector down, do not lift.
- The dark green safety guard pushes in and unlocks the purple start button.
13 Keep pushing the autoinjector down and press the purple start button to start the injection.
- You may hear or feel a click.
- The window starts to turn yellow.
- It is okay to let go of the purple start button.
14 Keep pushing the autoinjector down. Wait for the window to turn fully yellow.
- The injection may take up to
- You may hear or feel a click.
- After the window turns fully yellow, lift the autoinjector away from the skin.
- The dark green safety guard locks around the needle.
Completing the Injection and Disposal
15 Confirm a full dose of medicine was injected.
- Do not touch the dark green safety guard.
- A small drop of liquid on the injection site is okay.
16 Check the injection site.
- Do not rub the injection site.
- If there is blood, press a cotton ball or gauze pad on your injection site.
- Apply an adhesive bandage if necessary.
For more information or help call 1-800-77-AMGEN (1-800-772-6436).
17 Place the used autoinjector and white cap in an FDA-cleared sharps disposal.
- Do not reuse the autoinjector.
- Do not touch the dark green safety guard.
Additional information about your sharps disposal container
- made of a heavy-duty plastic,
- can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
- upright and stable during use,
- leak-resistant, and
- properly labeled to warn of hazardous waste inside the container.
Disposing of sharps disposal containers:
When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container.
There may be state or local laws about how you should throw away used needles and syringes.
For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at:
http://www.fda.gov/safesharpsdisposal
Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this.
Do not recycle your used sharps disposal container.
Keep the autoinjector and sharps disposal container out of the sight and reach of children.
AIMOVIG-oh-vig)
Manufactured by:
© 2018 – 2025 Amgen Inc.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Revised: 6/2025
9INSTRUCTIONS FOR USE AIMOVIG®[AIM-oh-vig] (erenumab-aooe) injection, for subcutaneous use mg/mL single-dose prefilled SureClick®autoinjector
This Instructions for Use contains information on how to inject AIMOVIG with a SureClick autoinjector.
If your healthcare provider decides that you or a caregiver may be able to give your injections of AIMOVIG at home, you should receive training on the right way to prepare and inject AIMOVIG. Do not try to inject yourself until you have been shown the right way to give the injections by your healthcare provider or nurse.
The medicine in the AIMOVIG autoinjector is for injection under the skin (subcutaneous injection). See the AIMOVIG
Storing and Preparing to Inject AIMOVIG
1 Refrigerate the autoinjector carton until you are ready to use it.
- Keep the autoinjector in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Keep the autoinjector in the original carton to protect it from light or physical damage.
- Do not freeze the autoinjector.
- Do not store the autoinjector in extreme heat or cold. For example, avoid storing in your vehicle's glove box or trunk.
3 You may keep AIMOVIG at room temperature for up to 7 days, if needed.
- For example, when you are traveling, you may keep AIMOVIG at room temperature.
4 Inspect the medicine. It should be clear and colorless to slightly yellow.
- It is okay to see air bubbles.
- Do not use the autoinjector if the medicine is cloudy, discolored, or contains flakes or particles.
5 Check the expiration date (Exp.) and inspect the autoinjector for damage.
- Do not use the autoinjector if the expiration date has passed.
- Do not use the autoinjector if:
- the orange cap is missing or loose in carton.
- it has cracks or broken parts, or
- it has been dropped on a hard surface.
Getting Ready to Inject AIMOVIG
6 Gather and place the following items for your injection on a clean, flat, and well-lit surface:
- AIMOVIG autoinjector (room temperature),
- Sharps disposal container [see
- Alcohol wipe,
- Adhesive bandage, and
- Cotton balls or gauze pads
7 Select 1 of these injection sites.
- Select the thigh or stomach (except for 2 inches around the belly button).
- Someone else can inject in your thigh, stomach, or back of the upper arm.
8 Wash your hands thoroughly with soap and water.
9 Clean the injection site with an alcohol wipe.
- Let the skin dry on its own.
- Do not touch this area again before injecting.
Injecting AIMOVIG
10 Grasp the autoinjector so you can see the window. Pull the orange cap straight off. You may need to pull hard.
- Do not twist, bend, or wiggle the orange cap to pull it off.
- Never put the orange cap back on. It may damage the needle.
- Do not put your finger inside the yellow safety guard.
- It is normal to see a drop of medicine come out of the needle or yellow safety guard.
11 Stretch or pinch the skin to create a firm surface at the injection site until the injection is finished. Place the yellow safety guard straight against the skin.
- Make sure you can see the window.
- Make sure the autoinjector is positioned straight on the injection site (at a 90-degree angle).
12 Firmly push the autoinjector down until the yellow safety guard stops moving. Hold the autoinjector down, do not lift.
- The yellow safety guard pushes in and unlocks the gray start button.
13 Keep pushing the autoinjector down and press the gray start button to start the injection.
- You may hear or feel a click.
- The window starts to turn yellow.
- It is okay to let go of the gray start button.
14 Keep pushing the autoinjector down. Wait for the window to turn fully yellow.
- The injection may take up to
- You may hear or feel a click.
- After the window turns fully yellow, lift the autoinjector away from the skin.
- The yellow safety guard locks around the needle.
Completing the Injection and Disposal
15 Confirm a full dose of medicine was injected.
- Do not touch the yellow safety guard.
- A small drop of liquid on the injection site is okay.
16 Check the injection site.
- Do not rub the injection site.
- If there is blood, press a cotton ball or gauze pad on your injection site.
- Apply an adhesive bandage if necessary.
For more information or help call 1-800-77-AMGEN (1-800-772-6436).
17 Place the used autoinjector and orange cap in an FDA-cleared sharps disposal.
- Do not reuse the autoinjector.
- Do not touch the yellow safety guard.
Additional information about your sharps disposal container
- made of a heavy-duty plastic,
- can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
- upright and stable during use,
- leak-resistant, and
- properly labeled to warn of hazardous waste inside the container.
Disposing of sharps disposal containers:
When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container.
There may be state or local laws about how you should throw away used needles and syringes.
For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at:
http://www.fda.gov/safesharpsdisposal
Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this.
Do not recycle your used sharps disposal container.
Keep the autoinjector and sharps disposal container out of the sight and reach of children.
AIMOVIG
Manufactured by:
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Revised: 6/2025
10Instructions for Use AIMOVIG®(AIM-oh-vig) (erenumab-aooe) Injection, For Subcutaneous Use Single-Dose Prefilled Syringe mg/mL and 140 mg/mL
Important: Needle is inside the gray needle cap.
Important
Before you use AIMOVIG prefilled syringe, read this important information:
Storing your AIMOVIG prefilled syringe
- Keep the syringe out of the reach of children.
- Keep the syringe in the original carton to protect from light.
- The syringe should be kept in the refrigerator at 36°F to 46°F (2°C to 8°C).
- After removing AIMOVIG from the refrigerator, it can be stored at room temperature between 68°F to 77°F (20°C to 25°C) for up to 7 days.
- Throw away AIMOVIG that has been left at room temperature for more than 7 days.
- Do not freeze.
Using your AIMOVIG prefilled syringe
- It is important that you do not try to give the injection unless you or your caregiver has received training from your healthcare provider.
- Do not use a syringe after the expiration date on the label.
- Do not shake the syringe.
- Do not remove the gray needle cap from the syringe until you are ready to inject.
- Do not use the syringe if it has been frozen.
- Do not use a syringe if it has been dropped on a hard surface. Part of the syringe may be broken even if you cannot see the break. Use a new syringe, and call 1-800-77-AMGEN (1-800-772-6436).
- The prefilled syringe is not made with natural rubber latex.
Step 1: Prepare
AIMOVIG comes as a single-dose (1 time) prefilled syringe. Your healthcare provider will prescribe the dose that is best for you.
Before you inject, always check the label of your single-dose prefilled syringe to make sure you have the correct medicine and the correct dose of AIMOVIG.
A Remove AIMOVIG prefilled syringe from the carton.
Grab the syringe barrel to remove the syringe from the tray.
For safety reasons:
- Do not grab the plunger rod.
- Do not grab the gray needle cap.
- Do not remove the gray needle cap until you are ready to inject.
- Do not remove the finger flange. This is part of the syringe.
Leave the syringe at room temperature for at least
- Do not put the syringe back in the refrigerator after it has reached room temperature.
- Do not try to warm the syringe by using a heat source such as hot water or microwave.
- Do not leave the syringe in direct sunlight.
- Do not shake the syringe.
Important: Always hold the prefilled syringe by the syringe barrel.
B Inspect the AIMOVIG prefilled syringe.
Always hold the syringe by the syringe barrel.
Make sure the medicine in the syringe is clear and colorless to slightly yellow.
- Do not use the syringe if the medicine is cloudy or discolored or contains flakes or particles.
- Do not use the syringe if any part appears cracked or broken.
- Do not use the syringe if the syringe has been dropped.
- Do not use the syringe if the gray needle cap is missing or not securely attached.
- Do not use the syringe if the expiration date printed on the label has passed.
In all cases, use a new syringe, and call 1-800-77-AMGEN (1-800-772-6436).
C Gather all materials needed for your injection.
Wash your hands thoroughly with soap and water.
On a clean, well-lit work surface, place the:
- New syringe
- Alcohol wipes
- Cotton balls or gauze pads
- Adhesive bandages
- Sharps disposal container
D Prepare and clean your injection site.
Only use these injection sites:
- Your thigh
- Stomach area (abdomen), except for a
- Outer area of upper arm (only if someone else is giving you the injection)
Clean your injection site with an alcohol wipe. Let your skin dry.
- Do not touch this area again before injecting.
- Do not inject into areas where the skin is tender, bruised, red, or hard. Avoid injecting directly into raised, thick, red, or scaly skin patch or lesion, or areas with scars or stretch marks.
Step 2: Get ready
E Pull gray needle cap straight out and away from your body, only when you are ready to inject. Do not leave the gray needle cap off for more than five minutes. This can dry out the medicine.
It is normal to see a drop of liquid at the end of the needle.
- Do not twist or bend the gray needle cap.
- Do not put the gray needle cap back onto the syringe.
- Do not remove the gray needle cap from the syringe until you are ready to inject.
Important: Throw the gray needle cap into the sharps disposal container.
F Pinch your injection site to create a firm surface.
Pinch skin firmly between your thumb and fingers, creating an area about
Important: Keep skin pinched while injecting.
Step 3: Inject
G Hold the pinch. With the gray needle cap off, insert the syringe into your skin at 45 to 90 degrees.
Do not place your finger on the plunger rod while inserting the needle.
H Place your finger on the plunger rod. Using slow and constant pressure, push the plunger rod all the way down until the prefilled syringe stops moving.
I When done, release your thumb, and gently lift the syringe off of your skin.
Important: When you remove the syringe, if it looks like the medicine is still in the syringe barrel, this means you have not received a full dose. Call your healthcare provider immediately.
Step 4: Finish
J Discard the used syringe and the gray needle cap.
Put the used AIMOVIG syringe and gray needle cap in a FDA-cleared sharps disposal container right away after use.
If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:
- Made of a heavy-duty plastic
- Can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out
- Upright and stable during use
- Leak-resistant
- Properly labeled to warn of hazardous waste inside the container
When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.
- Do not reuse the syringe.
- Do not recycle the syringe or sharps disposal container or throw them into household trash.
Important: Always keep the sharps disposal container out of the reach of children.
K Examine the injection site.
If there is blood, press a cotton ball or gauze pad on your injection site.
For more information, go to www.aimovig.com or call 1-800-77-AMGEN (1-800-772-6436).
AIMOVIG
Manufactured by:
© 2018-2022, 2024 Amgen Inc. All rights reserved.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
11PRINCIPAL DISPLAY PANEL - 70 mg/mL Syringe Carton
AMGEN
1 x 70 mg/mL Prefilled Syringe
aimovig
70
70 mg/mL
Single-dose Prefilled Syringe
For Subcutaneous Use Only
Store refrigerated at 2°C to 8°C (36°F to 46°F) in original
Before injecting, allow AIMOVIG to sit
Keep out of the sight and reach of children.
For more information, go to Aimovig.com or
CAUTION, Prior to use,
Do Not Reuse
Not made with
12PRINCIPAL DISPLAY PANEL - 70 mg/mL Autoinjector Carton
1 x 70 mg/mL Prefilled Autoinjector
aimovig
70
Aimovig.com/demo
70 mg/mL
Prefilled Autoinjector
For Subcutaneous Use Only
Store carton in refrigerator at 36°F to 46°F (2°C to 8°C).
Do Not Freeze or Shake.
Store in Carton to Protect from Light. Discard Any
Keep out of the sight and reach of children.
Not made with natural rubber latex
No U.S. standard of potency
CAUTION, Consult
Do not re-use
Refrigerate
Rx Only
AMGEN
13PRINCIPAL DISPLAY PANEL - 70 mg/mL Autoinjector Carton - Not for Sale
1 x 70 mg/mL Prefilled Autoinjector
aimovig
70
Aimovig.com/demo
70 mg/mL
Not for Sale
Prefilled Autoinjector
For Subcutaneous Use Only
Store carton in refrigerator at 36°F to 46°F (2°C to 8°C).
Do Not Freeze or Shake.
Store in Carton to Protect from Light. Discard Any
Keep out of the sight and reach of children.
Not made with natural rubber latex
No U.S. standard of potency
CAUTION, Consult
Do not re-use
Refrigerate
Rx Only
AMGEN
14PRINCIPAL DISPLAY PANEL - 140 mg/mL Autoinjector Carton
1 x 140 mg/mL Prefilled Autoinjector
aimovig
140
Aimovig.com/demo
140 mg/mL
Prefilled Autoinjector
For Subcutaneous Use Only
Store carton in refrigerator at 36°F to 46°F (2°C to 8°C).
Do Not Freeze or Shake.
Store in Carton to Protect from Light. Discard Any
Keep out of the sight and reach of children.
Not made with natural rubber latex
No U.S. standard of potency
CAUTION, Consult
Do not re-use
Refrigerate
Rx Only
AMGEN
15PRINCIPAL DISPLAY PANEL - 140 mg/mL Autoinjector Carton - Not for Sale
1 x 140 mg/mL Prefilled Autoinjector
aimovig
140
Aimovig.com/demo
140 mg/mL
Prefilled Autoinjector
Not for Sale
For Subcutaneous Use Only
Store carton in refrigerator at 36°F to 46°F (2°C to 8°C).
Do Not Freeze or Shake.
Store in Carton to Protect from Light. Discard Any
Keep out of the sight and reach of children.
Not made with natural rubber latex
No U.S. standard of potency
CAUTION, Consult
Do not re-use
Refrigerate
Rx Only
AMGEN
16PRINCIPAL DISPLAY PANEL - 140 mg/mL Syringe Carton
AMGEN
1 x 140 mg/mL Prefilled Syringe
aimovig
140
140 mg/mL
Single-dose Prefilled Syringe
For Subcutaneous Use Only
Store refrigerated at 2°C to 8°C (36°F to 46°F) in original
Before injecting, allow AIMOVIG to sit at
Keep out of the sight and reach of children.
For more information, go to Aimovig.com or
CAUTION, Prior to use,
Do Not Reuse
Not made with
